Why MBX Capital is Betting $100M on the Link Between Industrial Toxins and Chronic Disease
What You Should Know: – MBX Capital has secured over $100M in capital commitments to invest in early-stage biotech and health tech companies, specifically focusing on “deep health” solutions that…
CMMI debuts ACCESS Model to spur use of tech for chronic disease
The CMS Innovation Center has debuted a new model to encourage the use of technology to treat chronic diseases that could be a boon for health tech companies that have…
Wearable Health Tech: Innovations and Impacts on Chronic Disease Management
Just a few decades ago, for a patient to gain insight into their current health prognosis, they would have to set up an appointment with their provider. They would then…